Autres langues Celltrion Pharm, Inc.

Actions

A068760

KR7068760008

Produits pharmaceutiques

Cours en clôture Korea S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
38 100,00 ^KRW	-1,30%		-1,80%	-34,31%

12/02	Celltrion Pharm va annuler pour 14 milliards de wons de ses propres actions	RE
05/02	Celltrion Pharm : le résultat d'exploitation 2025 grimpe à 56 milliards de wons, en hausse de 50,7% sur un an	RE

Autres langues

21/09	Celltrion Pharm, Inc.(KOSDAQ:A068760) dropped from FTSE All-World Index
12/02	Celltrion Pharm to cancel 14 billion won worth of own shares
05/02	Celltrion Pharm 2025 operating profit 56 billion won, up 50.7% from year earlier
11/12	Celltrion Pharm, Inc. announces Annual dividend, payable on April 17, 2026
17/09/25	Celltrion Pharm, Inc. Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business
10/04/25	Celltrion Chairman, Affiliates to Buy KRW200 Billion in Stock
04/02/25	Celltrion Pharm Begins Domestic Sales of Amrozet Hypertension Drug; Shares Rise 3%
16/12/24	Celltrion, Inc.'s Equity Buyback announced on November 21, 2024, has closed with 583,431 shares, representing 1.41% for KRW 106,737.43 million.
21/11/24	Celltrion, Inc. authorizes a Buyback Plan.
03/09/24	Celltrion Pharm Introduces Three Biosimilars in South Korea
16/08/24	South Korean Shares Rally on Wall Street Gains as US Recession Fears Subside
16/08/24	Celltrion, Celltrion Pharm Merger Falls Out over Shareholder Activism
16/01/24	Celltrion Holdings Actively Pursuing Nasdaq Listing
02/01/24	Celltrion's Shares Climb After Merger With Affiliate
11/12/23	S.Korean shares end slightly higher as chipmakers advance; US CPI in focus
18/08/23	South Korean Shares Decline on Concerns over US Fed Rate Hike, China Economic Turmoil
18/08/23	Celltrion Discloses Merger Plans with Celltrion HealthCare; Celltrion Shares Jump 5%
20/03/23	Exclusive-Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources
07/03/23	South Korean Stocks Rise on Gains by Batterymakers; Samsung SDI Stock Rises 2%
07/03/23	Celltrion Group Creator Expected to Resume Leadership Role
21/01/22	Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill
17/09/21	Celltrion : South Korea approves Celltrion's COVID-19 treatment for use
15/12/20	Celltrion HealthCare : S.Korea Celltrion's candidate COVID-19 drug gets approval for special-case use
30/11/20	S.Korea stocks fall on rising virus cases, profit-booking
26/10/20	Samsung Electronics : S.Korea shares dip as surging global coronavirus cases dent sentiment